Protection During Cardiac Surgery.

NACompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

January 3, 2018

Primary Completion Date

May 30, 2019

Study Completion Date

July 3, 2019

Conditions
Thoracic SurgeryCardiopulmonary Bypass
Interventions
OTHER

multimodal cardioprotection strategy

Multimodal cardioprotection therapeutic strategy will include (1) remote ischemic preconditioning, (2) volatile anesthetic sevoflurane-induced preconditioning, (3) blood glucose control every 30 minutes during cardiac surgery, (4) temporary respiratory acidosis prior to the aortic cross-unclamping and (5) gradual restoration of blood flow after aortic cross-unclamping (gentle reperfusion).

OTHER

standard anesthetic procedure

standard anesthetic procedure will include: anesthesia under propofol throughout the cardiac surgery, blood glucose control every 60 minutes, arterial pH maintained at 7.40, theoric blood flow restored at the earliest after aortic cross-unclamping.

Trial Locations (8)

69500

Service d'Anesthésie-Réanimation, Hôpital Cardiologique et Pneumologique Louis Pradel, Bron

Unknown

CH Annecy, Annecy

CHU de Caen, Caen

service de Chirurgie Cardiaque CHU Gabriel Montpied, Clermont-Ferrand

Unité de Réanimation Cardiovasculaire et Thoracique, Hôpital Michallon, Grenoble

Clinique de la sauvegarde, Lyon

CHU Saint-Etienne, Saint-Etienne

Institut Arnault Tzanck - Saint-Laurent du Var, Saint-Laurent-du-Var

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03230136 - Protection During Cardiac Surgery. | Biotech Hunter | Biotech Hunter